Administration of balanced or BCAA-enriched amino acid solution in septic rats. Effects on protein synthesis in the liver.
Total hepatic protein synthesis was measured in vivo with a flooding-dose technique, and the production of total secreted proteins, albumin, complement component C3, and seromucoid fraction was measured in perfused livers of septic rats that received one of three different solutions infused intravenously; Group 1 received 16.4% dextrose; Group 2 received Aminosyn (25% BCAA) in 10.6% dextrose, and Group 3 received Freamine HBC (45% BCAA) in 10.6% dextrose. All solutions were isocaloric, and the amino acid solutions were isonitrogenous. The solutions were administered for 18 or 48 hours after the induction of sepsis. There were no significant differences in mortality rates in the three treatment groups. The negative nitrogen balance seen in the dextrose-infused animals was reversed to the same degree by the two different amino acid solutions. There were no significant differences in hepatic protein synthesis rates in vivo between the three groups of rats. Synthesis rates of secreted proteins in perfused liver were similar in the different treatment groups in the 18-hour experiments, whereas in the 48-hour experiments, synthesis rates of total secreted proteins, C3, and the serumucoid fraction were higher in Group 1 than in Groups 2 and 3. The results suggest that administration of an amino acid solution improves nitrogen balance in sepsis, but that this effect is not caused by stimulated hepatic protein synthesis. The nitrogen-sparing effect during sepsis of a branched chain amino acid (BCAA)-enriched solution does not seem to be superior to that of a balanced amino acid solution.
D000596:Amino Acids / Q000008:administration & dosage* / Q000494:pharmacology; D000597:Amino Acids, Branched-Chain / Q000008:administration & dosage* / Q000494:pharmacology; D000818:Animals; D001424:Bacterial Infections / Q000378:metabolism*; D001786:Blood Glucose / Q000032:analysis; D004573:Electrolytes; D005947:Glucose / Q000008:administration & dosage; D066298:In Vitro Techniques; D008099:Liver / Q000378:metabolism*; D008297:Male; D009584:Nitrogen / Q000378:metabolism; D010288:Parenteral Nutrition; D057947:Parenteral Nutrition Solutions; D014176:Protein Biosynthesis; D051381:Rats; D011919:Rats, Inbred Strains; D012996:Solutions
D000596:Amino Acids; D000597:Amino Acids, Branched-Chain; D001786:Blood Glucose; D004573:Electrolytes; D057947:Parenteral Nutrition Solutions; D012996:Solutions; C545824:amino-acid, glucose, and electrolyte solution; D005947:Glucose; D009584:Nitrogen